Data gathered: November 14
Alternative Data for Bio-Techne
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 61 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 175,000 | Sign up | Sign up | Sign up |
| Employee Rating | 70 | Sign up | Sign up | Sign up |
| Google Trends | 27 | Sign up | Sign up | Sign up |
| Patents | 34 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 6 | Sign up | Sign up | Sign up |
| Facebook Followers | 2,515 | Sign up | Sign up | Sign up |
| Instagram Followers | 1,555 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 519 | Sign up | Sign up | Sign up |
| Twitter Followers | 2,338 | Sign up | Sign up | Sign up |
| Twitter Mentions | 60 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 2,940 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 51 | Sign up | Sign up | Sign up |
| Linkedin Employees | 2,770 | Sign up | Sign up | Sign up |
About Bio-Techne
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide.
| Price | $72.54 |
| Target Price | Sign up |
| Volume | 1,210,000 |
| Market Cap | $11.9B |
| Year Range | $61.99 - $84.06 |
| Dividend Yield | 0.43% |
| PE Ratio | 78.62 |
| Analyst Rating | 71% buy |
| Industry | Biotechnology |
In the news
 |
Amalgamated Bank Lowers Stake in Bio-Techne Co. (NASDAQ:TECH)November 12 - ETF Daily News |
UPDATED, BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORSNovember 11 - Finnhub |
|
 |
UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORSNovember 11 - Yahoo |
BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORSNovember 11 - Finnhub |
|
BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCESNovember 10 - Finnhub |
|
|
Bio-Techne Co. (NASDAQ:TECH) Receives $81.78 Consensus PT from AnalystsNovember 9 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 290M | 251M | 183M | 34M | 60M | 0.420 |
| Q2 '24 | 320M | 21M | 203M | 41M | 66M | 0.490 |
| Q1 '24 | 299M | 212M | 205M | 49M | 85M | 0.480 |
| Q4 '23 | 268M | 223M | 177M | 27M | 58M | 0.400 |
| Q3 '23 | 272M | 217M | 185M | 51M | 75M | 0.410 |
Insider Transactions View All
| BAUMGARTNER ROBERT V filed to sell 43,401 shares at $72.1. August 12 '24 |
| HIGGINS JOHN L filed to sell 36,608 shares at $83.8. May 16 '24 |
| Nusse Roeland filed to sell 43,097 shares at $77. March 11 '24 |
| Nusse Roeland filed to sell 51,872 shares at $80.3. September 1 '23 |
| Kummeth Charles R. filed to sell 1,258,766 shares at $88.4. July 25 '23 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Rohit Khanna Democrat |
Jun 5, 24 | Buy | $1K - $15K |
| Rohit Khanna Democrat |
May 6, 24 | Sell | $1K - $15K |
| Rohit Khanna Democrat |
Nov 8, 23 | Buy | $1K - $15K |
Read more about Bio-Techne (TECH) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Bio-Techne?
The Market Cap of Bio-Techne is $11.9B.
What is Bio-Techne's PE Ratio?
As of today, Bio-Techne's PE (Price to Earnings) ratio is 78.62.
What is the current stock price of Bio-Techne?
Currently, the price of one share of Bio-Techne stock is $72.54.
How can I analyze the TECH stock price chart for investment decisions?
The TECH stock price chart above provides a comprehensive visual representation of Bio-Techne's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Bio-Techne shares. Our platform offers an up-to-date TECH stock price chart, along with technical data analysis and alternative data insights.
Does TECH offer dividends to its shareholders?
Yes, Bio-Techne (TECH) offers dividends to its shareholders, with a dividend yield of 0.43%. This dividend yield represents Bio-Techne's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Bio-Techne in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Bio-Techne?
Some of the similar stocks of Bio-Techne are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.